Paraneoplastic Musculoskeletal Syndromes.

Area of Science:

• Oncology
• Rheumatology
• Internal Medicine

Background:

• Paraneoplastic syndromes are rare disorders triggered by cancer, distinct from direct tumor effects.
• These syndromes can manifest as initial, potentially fatal, indicators of an underlying malignancy.
• Paraneoplastic rheumatic syndromes are associated with various cancers, including hematologic, lymphoproliferative, and solid tumors.

Purpose of the Study:

• To highlight the significance of paraneoplastic syndromes in oncology and rheumatology.
• To emphasize the potential for paraneoplastic phenomena to be the earliest detectable sign of cancer.
• To guide clinicians in suspecting paraneoplastic syndromes based on specific clinical features.

Main Methods:

• Review of literature on paraneoplastic syndromes and their association with malignancies.
• Analysis of clinical characteristics that warrant suspicion for paraneoplastic phenomena.
• Correlation of paraneoplastic rheumatic syndromes with specific cancer types.

Main Results:

• Paraneoplastic syndromes represent a diverse group of conditions linked to malignancies.
• These syndromes can precede cancer diagnosis and carry a significant mortality risk.
• Specific patient factors, including advanced age, constitutional symptoms, and poor treatment response, are indicative of paraneoplastic syndromes.

Conclusions:

• Paraneoplastic syndromes require a high index of suspicion, especially in patients with atypical disease presentations.
• Early recognition and diagnosis of paraneoplastic syndromes are crucial for timely cancer management and improved patient outcomes.
• Understanding the link between rheumatic manifestations and underlying cancers is vital for comprehensive patient care.